603139.SS Stock Analysis
60
Uncovered
Shaanxi Kanghui Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of Chinese medicine. The company is headquartered in Xianyang, Shaanxi and currently employs 812 full-time employees. The company went IPO on 2017-04-21. The firm's main products include Kun Fu Kang capsules (tablets), Fufang Shuanghua tablets, Xiaoyin granules, Fuguigutong capsules, Zhiyao Xiaoke capsules and Fufang Qingdai perfusates. The firm distributes its products just within China domestic market.